Is FSCRX or JNJ a better dividend investment in 2026?

FSCRX currently yields 15.41% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: FSCRX offers higher current income.

What is the dividend yield difference between FSCRX and JNJ?

FSCRX has a forward dividend yield of 15.41% ($3.42/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 12.05 percentage points.

Home › Compare › FSCRX vs JNJ

FSCRX vs JNJ: Dividend Comparison 2026

FSCRX yields 15.41% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FSCRX wins by $34.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FSCRX

● Live price

15.41%

Share price

$22.21

Annual div

$3.42

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$54.9K

Annual income

$3,987.42

Full FSCRX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — FSCRX vs JNJ

📍 FSCRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FSCRX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FSCRX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FSCRX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSCRX

Annual income on $10K today (after 15% tax)

$1,310.02/yr

After 10yr DRIP, annual income (after tax)

$3,389.31/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, FSCRX beats the other by $2,685.69/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSCRX + JNJ for your $10,000?

FSCRX: 50%JNJ: 50%

100% JNJ50/50100% FSCRX

Portfolio after 10yr

$37.5K

Annual income

$2,407.60/yr

Blended yield

6.43%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FSCRX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSCRX buys

JNJ buys

No recent congressional trades found for FSCRX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFSCRXJNJ

Forward yield	15.41% ✓	3.36%
Annual dividend / share	$3.42	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$54.9K ✓	$20.0K
Annual income after 10y	$3,987.42 ✓	$827.78
Total dividends collected	$27.0K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: FSCRX vs JNJ ($10,000, DRIP)

Year	FSCRX Portfolio	FSCRX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,241	$1,541.20	$10,676	$355.77	+$1.6K → FSCRX
2	$14,861	$1,763.19	$11,407	$389.39	+$3.5K → FSCRX
3	$17,902	$2,000.54	$12,198	$426.53	+$5.7K → FSCRX
4	$21,407	$2,252.22	$13,056	$467.62	+$8.4K → FSCRX
5	$25,423	$2,517.03	$13,987	$513.12	+$11.4K → FSCRX
6	$29,996	$2,793.61	$14,998	$563.56	+$15.0K → FSCRX
7	$35,176	$3,080.51	$16,098	$619.52	+$19.1K → FSCRX
8	$41,015	$3,376.17	$17,295	$681.69	+$23.7K → FSCRX
9	$47,565	$3,679.01	$18,599	$750.82	+$29.0K → FSCRX
10	$54,882	$3,987.42	$20,022	$827.78	+$34.9K → FSCRX

FSCRX vs JNJ: Complete Analysis 2026

FSCRX — Stock

The fund normally invests at least 80% of assets in securities of companies with small market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell 2000® Index or the S&P SmallCap 600® Index). It invests in domestic and foreign issuers. The fund invests in either growth stocks or value stocks or both. The advisor uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Full FSCRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this FSCRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSCRX vs SCHD FSCRX vs JEPI FSCRX vs O FSCRX vs KO FSCRX vs MAIN FSCRX vs ABBV FSCRX vs MRK FSCRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.